PubRank

Masahiro Mori

Author PubWeight™ 5.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2020 3.93
2 Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2014 0.87
3 Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria. Mult Scler 2015 0.83
4 Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2014 0.79
5 Steroid-Responsive Epilepsia Partialis Continua with Anti-Thyroid Antibodies: A Spectrum of Hashimoto's Encephalopathy? Case Rep Neurol 2014 0.79
6 Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption. Mult Scler 2016 0.76
7 Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited. J Neuroimmunol 2014 0.76
8 Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies. J Neurol Neurosurg Psychiatry 2015 0.75
9 Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis? J Neurol Neurosurg Psychiatry 2014 0.75
10 Nodopathy: chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 antibodies. J Neurol Neurosurg Psychiatry 2017 0.75
11 Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. PLoS One 2017 0.75
12 Benign neuromyelitis optica is rare in Japanese patients. Mult Scler 2014 0.75
13 A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain. Clin Neurol Neurosurg 2013 0.75
14 Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis. J Neurol Sci 2015 0.75
15 Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry 2017 0.75